SAVA FILANA THERAPEUTICS, INC.: institutional ownership and insider trading
Over the last 12 months insiders bought $997K and sold $0 on the open market.
SAVA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$8.60M
- Quarter ended Mar 31, 2026: revenue n/a, net income −$10.3M
- Quarter ended Dec 31, 2025: revenue n/a, net income −$12.5M, EPS -0.26
- Quarter ended Sep 30, 2025: revenue n/a, net income −$10.8M, EPS -0.22
Recent SAVA insider trades
- Sep 30, 2026: Barry Richard bought 306,813 shares ($278K)
- Sep 28, 2026: Barry Richard bought 93,091 shares ($78.2K)
- Nov 24, 2025: Anderson Robert Eugene Jr bought 8,600 shares ($24.9K)
- Nov 20, 2025: Barry Richard bought 150,000 shares ($414K)